Australia markets closed

Nascent Biotech, Inc. (NBIO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.09980.0000 (0.00%)
At close: 01:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
0
0
1,000
750
Operating expenses
Research development
183.414
270.529
197.406
321.938
Selling general and administrative
1,670
1,502
927.357
1,828
Total operating expenses
2,238
2,156
1,457
2,150
Operating income or loss
-2,238
-2,156
-457.052
-1,400
Interest expense
1,091
1,723
335.983
336.632
Total other income/expenses net
942.836
1,083
473.823
797.644
Income before tax
-2,093
-2,801
-470.39
-958.767
Income tax expense
-
0
0
0
Income from continuing operations
-2,093
-2,801
-470.39
-958.767
Net income
-2,093
-2,801
-470.39
-958.767
Net income available to common shareholders
-2,093
-2,801
-470.39
-958.767
Basic EPS
-0.02
-0.02
-0.00
-0.01
Diluted EPS
-0.02
-0.02
-0.00
-0.01
Basic average shares
132,544
118,569
107,742
72,342
Diluted average shares
132,544
118,569
107,742
72,342